Clinical Trials Sponsored by Ana Radovic

Total 53285 results

Radovan Uvizl

Unknown

The Benefits of Early Initiation of Continual Renal Replacement Therapy in Patients With Severe Sepsis

Severe Sepsis
Ana Radovic
National Institute of Mental Health (NIMH); University of Virginia; NuRelm, Inc.

Active, not recruiting

Evaluation of MoodRing on Improving the Quality of Depression Management in Adolescents (TECH-E)

Depression in Adolescence

United States
University Paul Sabatier of Toulouse
LUCAS BATISTELLA, MD; Kheira hireche, MD; Ludovic CANAUD, MD PhD

Active, not recruiting

Rolled Pericardium Versus Cryopreserved Allograft to Treat Native or Prosthetic Aortic Infection

Aortic Infections and Inflammations
University Hospital Heidelberg
Kieser Training Offenbach / Marko Babovic; Kieser Training AG Zürich / Dr....

Completed

Effects of Kieser Resistance Training Plus Kieser Pelvic Floor Training vs. Kieser Resistance Training Plus Traditional Pelvic Floor Exercise on Urinary Incontinence in Prostate Cancer Patients After Radical Prostatectomy (RECON)

Prostate Cancer | Pelvic Floor Disorders | Incontinence, Urinary | Prostate Ectomy

Germany
Region Skane
Anna and Edwin Berger Foundation

Completed

Preoperative Biochemical Predictors of Outcome in Patients With Hip Fracture

Hip Fracture

Sweden
Hospital Ana Nery

Completed

Sildenafil Impact on Ventricular Function in Patients With Heart Failure

Heart Failure

Brazil
Hospital Ana Nery

Unknown

Intensive Versus Conventional Digoxin Use in Patients With Heart Failure (ICHF)

Heart Failure

Brazil
Hospital Ana Nery

Terminated

Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation Postoperatively (DAWA)

Primary Disease

Brazil
Aga Khan University
Bill and Melinda Gates Foundation

Completed

Impact of Pulse Oximetry on Hospital Referral Acceptance in Children Under 5 With Severe Pneumonia

Hypoxemia | Severe Pneumonia

Pakistan
Reza Dana, MD

Completed

Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival

Corneal Neovascularization | Corneal Graft Failure

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Terminated

Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate

Malignant Pleural Mesothelioma | Pleural Mesothelioma

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Terminated

Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer

NSCLC | Lung Cancer | Non-small Cell Lung Cancer

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate

Malignant Pleural Mesothelioma | Pleural Mesothelioma

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy

Hodgkin's Disease

United States
Reza Dana, MD

Completed

Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV)

Corneal Neovascularization

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation

Multiple Myeloma | Hodgkin's Lymphoma | AML | Hematologic Malignancy | NHL | CML | ALL

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia

Acute Myelogenous Leukemia | Myelodysplasia

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome | Acute Myelogenous Leukemia

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Dynamic Area Telethermometry (DAT) as an Imaging Modality in Patients With Cancer

Malignant Tumors | Subcutaneous Tumors | Lymph Node Tumors

United States
Dana-Farber Cancer Institute
Eli Lilly and Company

Recruiting

Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia

Waldenstrom Macroglobulinemia

United States
Dana-Farber Cancer Institute
Eli Lilly and Company

Recruiting

Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-type Cyclins or Amplification of CDK4 or CDK6

Cancer

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Recruiting

Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial

Brain Metastases

United States
Dana-Farber Cancer Institute
Eli Lilly and Company

Terminated

Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer

Breast Cancer

United States
Dana-Farber Cancer Institute
Eli Lilly and Company

Active, not recruiting

A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors

Carcinoid Tumors

United States
Dana-Farber Cancer Institute
Eli Lilly and Company

Active, not recruiting

ABEMA Alone or in COMBO With MK-6482

Clear Cell Renal Cell Carcinoma

United States
Aga Khan University
Bill and Melinda Gates Foundation

Completed

Implementation at Scale and Evaluation of KMC (KMC)

Newborn Morbidity

Pakistan
Dana-Farber Cancer Institute
Eli Lilly and Company

Active, not recruiting

LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma

Melanoma

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Autologous Vaccination With Lethally Irradiated, Autologous Breast Cancer Cells Engineered to Secrete GM-CSF in Women With Operable Breast Cancer

Breast Cancer

United States
Aga Khan University
Bill and Melinda Gates Foundation

Completed

Community Mobilization and Incentivization for Childhood Diarrhea and Pneumonia (CoMIC)

Childhood Diarrhea | Childhood Pneumonia | Community Mobilisation | Sanitation and Hygiene | Community Incentives

Pakistan
Indus Hospital and Health Network
Aga Khan University

Unknown

Comparison of Surgical Site Infection After Skin Closure by Prolene or Staples in Bilateral Knee Arthroplasty Patients

Total Knee Replacement
Indus Hospital and Health Network
Aga Khan University

Unknown

Gum Chewing Reduces the Risk of Postoperative Ileus After Arthroplasty Procedures in The Elderly Population

Paralytic Ileus
Aga Khan University
Bill and Melinda Gates Foundation

Unknown

Implementation Research of Kangaroo Mother Care in Rural Pakistan. (KMC)

Low-Birth-Weight Infant

Pakistan
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

PET/CT-Assessment of Liver Tumor Ablation

Liver Neoplasms | Liver Tumor

United States
Dana-Farber Cancer Institute
Eli Lilly and Company

Withdrawn

ERK 1/2 Signaling in Ibrutinib Resistant B-cell Malignancies

Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Cosmetic Result/Toxicity in Post-Mastectomy Immediate Reconstruction Expander+RT

Breast Cancer

United States
Dana-Farber Cancer Institute
Eli Lilly and Company

Terminated

Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial

Acute Myeloid Leukemia | Myelodysplastic Syndromes

United States
Reza Dana, MD

Completed

Topical IL-1-Ra for Treatment of Posterior Blepharitis

Posterior Blepharitis
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

FLT PET/CT for Staging, Target Definition and Assessment of Response to Therapy in Patients With Esophageal Cancer

Esophageal Cancer

United States
Reza Dana, MD

Terminated

Topical IL-1-Ra for Treatment of Corneal Neovascularization

Corneal Neovascularization

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

United States
Brigham and Women's Hospital
Dana-Farber Cancer Institute

Completed

Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma

Malignant Pleural Mesothelioma

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

A-protein Levels in Adult and Pediatric Brain Tumor Patients

Malignant Childhood Central Nervous System Neoplasm

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Socialization of Adult Men With Congenital Hemophilia A or B (PWBCD)

Hemophilia A | Hemophilia B

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer

Adenocarcinoma of Esophagus | Squamous Cell Carcinoma of Esophagus

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation

Graft Versus Host Disease | GVHD

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Terminated

Hypertension in Breast Cancer Patients Receiving Bevacizumab

Breast Cancer

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma

Malignant Pleural Mesothelioma | Pleural Mesothelioma

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

High Dose Ara-C (HDAC) and Interleukin-2 (IL-2) for Patients With Acute Myelogenous Leukemia (AML)

Acute Myelogenous Leukemia

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Educational Interventions for Patients With DCIS

DCIS

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Terminated

High Dose Rate Intracavitary Brachytherapy as the Sole Method of Radiation Therapy for Breast Carcinoma

Breast Cancer

United States

Clinical Trials Sponsored by Ana Radovic

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations